García-Mayor R V, Pérez Mendez L F, Páramo C, Luna Cano R, Rego Iraeta A, Regal M, Sierra J M, Fluiters E
Endocrine Service, General Hospital of Vigo, Spain.
J Endocrinol Invest. 1997 Sep;20(8):482-7. doi: 10.1007/BF03348005.
The aim of the present study was to analyze the changes in our clinical practice due to the use of FNAB in the management of nodular thyroid disease. Patients attended the thyroid unit for thyroid nodules. The study comprises three periods: First, from January 1980 to May 1984, 226 patient. Second, from June 1985 to December 1990, 166 patients. Third, from January 1991 to December 1993, 403 patients.
retrospective the 1st period and prospective the 2nd and 3rd periods. During the 1st and 2nd periods, decision for surgery was based on clinical parameters together with results of 99Tc radionucleotide scan and B mode ultrasound studies. In the 3rd period surgical decision was based principally on cytologic results. We comparatively studied the frequency of surgical operation and frequency of malignancy in surgical thyroid specimens between the study periods. Determination of sensitivity, specificity and accuracy of the diagnostic methods was done. We observed a decrease in the frequency of patients requiring surgery, 89.9%, 67.8% and 46.6% for the 1st, 2nd and 3rd study periods, X2 = 114.7, p < 0.0001; and an increase in the frequency of malignancy in the surgical specimens, 14.7%, 24.4% and 32.9% for 1st, 2nd and 3rd periods respectively, X2 = 4.5, p < 0.05. The sensitivity 92.5% and 93.5%, the specificity 50.6% and 61.1%, and the accuracy 60.9% and 71.8% of the FNAB for the second and third periods respectively. The rates of false negative cytological specimens were 1.8% and 2.1% for 2nd and 3rd respectively, p > 0.05. Since the introduction of FNAB in the evaluation of our patients around 70% of these had a definitive preoperative diagnosis of either benign or malignant disease. Simplification in management of patients with nodular thyroid disease is the most important impact for the use of FNAB. Furthermore, a decrease in the number of patients requiring surgical treatment and an increase of malignant nodules in the specimens obtained by surgery were also observed. We think that FNAB is the most direct and accurate method in the management of patients with thyroid nodules.
本研究的目的是分析在结节性甲状腺疾病管理中使用细针穿刺抽吸活检(FNAB)导致的我们临床实践中的变化。患者因甲状腺结节就诊于甲状腺科。该研究包括三个阶段:第一阶段,从1980年1月至1984年5月,共226例患者;第二阶段,从1985年6月至1990年12月,共166例患者;第三阶段,从1991年1月至1993年12月,共403例患者。
第一阶段为回顾性研究,第二和第三阶段为前瞻性研究。在第一和第二阶段,手术决策基于临床参数以及99Tc放射性核素扫描和B型超声检查结果。在第三阶段,手术决策主要基于细胞学结果。我们比较研究了各研究阶段手术操作的频率以及手术切除的甲状腺标本中恶性肿瘤的频率。对诊断方法的敏感性、特异性和准确性进行了测定。我们观察到需要手术的患者频率下降,第一、第二和第三研究阶段分别为89.9%、67.8%和46.6%,X2 = 114.7,p < 0.0001;手术标本中恶性肿瘤的频率增加,第一、第二和第三阶段分别为14.7%、24.4%和32.9%,X2 = 4.5,p < 0.05。FNAB在第二和第三阶段的敏感性分别为92.5%和93.5%,特异性分别为50.6%和61.1%,准确性分别为60.9%和71.8%。第二和第三阶段细胞学标本的假阴性率分别为1.8%和2.1%,p > 0.05。自从在我们对患者的评估中引入FNAB以来,约70%的患者在术前得到了良性或恶性疾病的明确诊断。FNAB的使用对结节性甲状腺疾病患者管理的最重要影响是简化了管理。此外,还观察到需要手术治疗的患者数量减少以及手术获取的标本中恶性结节数量增加。我们认为FNAB是管理甲状腺结节患者最直接和准确的方法。